Consumer group wants halt on review of Lilly drug

WASHINGTON - U.S. Consumer health advocates and a patent holder on a highly anticipated blood thinner from Eli Lilly are calling on the Food and Drug Administration to halt its review of the drug, which they say may be unsafe at the suggested dose....More